⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CBIO News
Crescent Biopharma, Inc. Common Stock
Form 8-K
sec.gov
CBIO
Crescent Biopharma Reports First Quarter 2026 Financial Results and Recent Business Highlights
globenewswire.com
CBIO
Crescent Biopharma Announces Grants of Inducement Awards
globenewswire.com
CBIO
Follicular Lymphoma Clinical Trial Space Intensifies with 45+ Companies in Active Development | DelveInsight
globenewswire.com
AZN
CRSP
NKTR
INCY
IPHA
ABBV
BIIB
ALKS
IMVT
CLRB
IMPP
REGN
THO
AUTL
KYMR
CBIO
GILD
Crescent Biopharma Announces Grants of Inducement Awards
globenewswire.com
CBIO
Continuity Biosciences et Breakthrough T1D entrent en collaboration pour soutenir la plateforme de thérapie cellulaire NICHE® en vue d'une première étude chez l'humain USA - Français Middle East - English USA - English Korea - 한국어 USA - Deutsch USA -
prnewswire.com
CBIO
Continuity Biosciences y Breakthrough T1D colaboran para impulsar la plataforma de terapia celular NICHE® USA - español Middle East - English USA - English Korea - 한국어 USA - Deutsch
prnewswire.com
CBIO
Continuity Biosciences und Breakthrough T1D arbeiten zusammen, um die NICHE®-Zelltherapie-Plattform auf dem Weg zur First-in-Human-Studie voranzubringen USA - Deutsch Middle East - English USA - English Korea - 한국어
prnewswire.com
CBIO
Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE® Cell-Therapy Platform Toward First-in-Human Study USA - English Middle East - English
prnewswire.com
CBIO
Cellipont Bioservices and BobcatBio Announce Strategic Collaboration to Advance Macrophage Cell Therapy for Solid Tumors
prnewswire.com
CBIO